课题基金 / 基金详情

CORE--ANIMAL MODELS

CORE--ANIMAL MODELS
核心--动物模型
批准号:
7100667
负责人:
TERRY A VAN DYKE
金额:
$16.82万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-12-01 至 2009-11-30

项目摘要

项目成果

TERRY A VAN DYKE的其他基金

相似基金

相关文献

中文摘要
翻译
综合癌症中心(UNC LCCC)和UNC生物技术和分子生物学项目(PMBB)。该设施的目标是以合理的成本为北卡罗来纳大学的研究人员提供转基因小鼠和支持技术,并支持癌症中心对人类疾病小鼠模型的战略重点。长期目标是建立一个最先进的设施,提供广泛的基因表达和删除策略。老鼠的实验操作已经成为研究癌症机制和生成许多人类疾病模型的有力工具。鉴于普遍
英文摘要
Comprehensive Cancer Center (UNC LCCC) and the UNC Program in Biotechnology and Molecular Biology (PMBB). The objective of the facility is to provide genetically modified mice and supporting technologies to UNC researchers at a reasonable cost and to support the Cancer Center's strategic emphasis on mouse models of human disease. The long-term goal is to build a state-of-the-art facility that provides a wide array of gene expression and deletion strategies. Experimental manipulation of the mouse has become a powerful tool for the study of cancer mechanisms and for the generation of many human disease models. Given widespread cell specificity, physiological complexities, and the dynamic nature of cancer development, animal models can be essential reagents in etiologic, prevention and treatment research. The objectives of this facility are to: Advise investigators in the design and follow-up of animal experiments, Generate genetically modified cells and animals for individual research programs, Provide basic support technologies (e.g., gamete and embryo cryopreservation), Use and develop new reagents and technologies (e.g., nuclear transfer), Decrease cost by centralizing functions such as genotyping. The Core is led by Drs. Terry Van Dyke (Faculty Director) and Randy Thresher (Facility Director). The Core adds value to the Center by providing highly skilled services at reasonable costs. Highlights of research supported by the Core include the production of glioblastoma and breast cancer models. The Core supports a new function, mouse genotyping, for: i) routine and timely genotyping to improve colony management; ii) marker-assisted generation of"speed congenics"; and iii) high throughput genome scans to help identify modified genes. Future plans for the Core include ICSI and cloning, lentivirus-based transgenics, high throughput vector construction, new ES cell line derivation and the production of strain 129-based Cre expressing lines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PRECLINICAL MOUSE MODELS: CENTRAL NERVOUS SYSTEM CANCERS
PRECLINICAL MOUSE MODELS: CENTRAL NERVOUS SYSTEM CANCERS
PRECLINICAL MOUSE MODELS: CENTRAL NERVOUS SYSTEM CANCERS
Animal Models Core
海外基金